Management of low-grade cervical lesions in young women

Lau, Susie; Franco, Eduardo L.
September 2005
CMAJ: Canadian Medical Association Journal;9/27/2005, Vol. 173 Issue 7, p771
Academic Journal
Provides information on the management of low-grade cervical lesions in young women. Information on cervical intraepithelial neoplasia; Reason for the increased risk of squamous intraepithelial lesion; Importance of human papillomavirus vaccines to cervical cancer prevention.


Related Articles

  • Human Papillomavirus through the Ages. Winer, Rachel L.; Koutsky, Laura A. // Journal of Infectious Diseases;6/1/2005, Vol. 191 Issue 11, p1787 

    The article highlights age-related trends in human papillomavirus (HPV) infection, with a particular emphasis on infections detected early and late in life. Most of the worldwide burden of cervical cancer is attributable to HPV infections acquired during the reproductive years. In the era of...

  • Knowledge of Health Care Providers on HPV Related Issues in Cervical Cancer. HUSSAIN, F.; FLORA, M. S.; NAHAR, K.; KHAN, M. // Journal of Bangladesh College of Physicians & Surgeons;Oct2011, Vol. 29 Issue 4, p213 

    Background: The field of cervical cancer prevention is rapidly evolving because of identification of Human Papilloma Virus (HPV) as the necessary cause of disease. HPV vaccines are now in the market.For successful triggering of cervical cancer prevention program, HPV informations should be...

  • Can 2009 herald a new era in preventing cervical cancers? Robinson-Bennett, Bernice // Journal of Carcinogenesis;2009, Vol. 8 Issue 1, p1 

    The author discusses the efforts towards the prevention and treatment of cervical cancer. She mentions that the a treatment called radical trachelectomy has been developed, which involves the removal of the cervix along with the tumor. She adds that efforts are also been made in producing...

  • HPV and Cervical Cancer. Leaver, Dennis; Labonte, Geri // Radiation Therapist;Spring2010, Vol. 19 Issue 1, p27 

    Human papillomaviruses (HPVs) are estimated to cause a half million cases of cervical cancer worldwide each year. This article reviews the connection between HPVs and cervical cancer, discusses the HPV vaccine and provides an overview of cervical cancer symptoms, staging and treatment. Case...

  • Lessons from the Failure of Human Papillomavirus Vaccine State Requirements. Schwartz, J. L.; Caplan, A. L.; Faden, R. R.; Sugarman, J. // Clinical Pharmacology & Therapeutics;Dec2007, Vol. 82 Issue 6, p760 

    The licensure in 2006 of a vaccine against the subtypes of human papillomavirus (HPV) responsible for the majority of cervical cancers and genital warts was heralded as a watershed moment for vaccination, cancer prevention, and global health.1 A safe and effective vaccine against HPV has long...

  • human papillomavirus, vaccines and cervical cancer prevention. Cadman, Louise // Learning Disability Practice;Nov2006, Vol. 9 Issue 9, p38 

    The article focuses on the development of a prophylactic vaccine for prevention of papillomavirus and cervical cancer that would likely exist to women in Great Britain. The occurrence of such diseases have been recognized by health professionals to exist mostly in women with disabilities because...

  • A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study. Brabin, L.; Roberts, S. A.; Stretch, R.; Baxter, D.; Elton, P.; Kitchener, H.; McCann, R. // British Journal of Cancer;11/3/2009, Vol. 101 Issue 9, p1502 

    Background:There is little information on girls' experiences of human papillomavirus (HPV) vaccination in the prevention of cervical cancer. We investigated the views of adolescent girls who had been offered the vaccine as part of a feasibility study conducted in Manchester.Methods:All 12 to...

  • Selecting a Mix of Prevention Strategies against Cervical Cancer for Maximum Efficiency with an Optimization Program. Demarteau, Nadia; Breuer, Thomas; Standaert, Baudouin // PharmacoEconomics;2012, Vol. 30 Issue 4, p337 

    Background: Screening and vaccination against human papillomavirus (HPV) can protect against cervical cancer. Neither alone can provide 100% protection. Consequently it raises the important question about the most efficient combination of screening at specified time intervals and vaccination to...

  • What If Preventing Cancer Is as Easy as Being Vaccinated? Biedrzycki, Barbara A. // ONS News;Aug2006, Vol. 21 Issue 8, p9 

    The article reports on the development of a human papillomavirus (HPV) vaccine intended for the prevention of cervical cancer among men and women worldwide. HPV has been sought to be the most common sexually transmitted disease with 20 million men and women have been infected. With the approval...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics